Troponin I Mutations R146G and R21C Alter Cardiac Troponin Function,Contractile Properties,and Modulation by Protein Kinase A (PKA)-mediated Phosphorylation

Two hypertrophic cardiomyopathy-associated cardiac troponin I (cTnI) mutations, R146G and R21C, are located in different regions of cTnI, the inhibitory peptide and the cardiac-specific N terminus. We recently reported that these regions may interact when Ser-23/Ser-24 are phosphorylated, weakening the interaction of cTnI with cardiac TnC. Little is known about how these mutations influence the affinity of cardiac TnC for cTnI (K_C-I) or contractile kinetics during β-adrenergic stimulation. Here, we tested how cTnI^R146G or cTnI^R21C influences contractile activation and relaxation and their response to protein kinase A (PKA). Both mutations significantly increased Ca²⁺ binding affinity to cTn (K_Ca) and K_C-I. PKA phosphorylation resulted in a similar reduction of K_Ca for all complexes, but K_C-I was reduced only with cTnI^WT. cTnI^WT, cTnI^R146G, and cTnI^R21C were complexed into cardiac troponin and exchanged into rat ventricular myofibrils, and contraction/relaxation kinetics were measured ± PKA phosphorylation. Maximal tension (T_max) was maintained for cTnI^R146G- and cTnI^R21C-exchanged myofibrils, and Ca²⁺ sensitivity of tension (pCa₅₀) was increased. PKA phosphorylation decreased pCa₅₀ for cTnI^WT-exchanged myofibrils but not for either mutation. PKA phosphorylation accelerated the early slow phase relaxation for cTnI^WT myofibrils, especially at Ca²⁺ levels that the heart operates in vivo. Importantly, this effect was blunted for cTnI^R146G- and cTnI^R21C-exchanged myofibrils. Molecular dynamics simulations suggest both mutations inhibit formation of intra-subunit contacts between the N terminus and the inhibitory peptide of cTnI that is normally seen with WT-cTn upon PKA phosphorylation. Together, our results suggest that cTnI^R146G and cTnI^R21C blunt PKA modulation of activation and relaxation kinetics by prohibiting cardiac-specific N-terminal interaction with the cTnI inhibitory peptide.